NEI Research News

New research funded by the National Eye Institute at the University of California, Los Angeles has uncovered details about the muscle that controls blinking, offering a pathway toward developing blink-assisting prostheses.

A team led by researchers at Mount Sinai has identified in mice a potential therapeutic target for dry eye disease.

Researchers have discovered a connection between levels of specific proteins in patients’ tears and persistent pain months after surgery such as LASIK.

A team of scientists have received funding to explore new approaches to disentangle intricate nerve networks in the cornea and discover which nerve makes people blink, which creates tears and which nerve tells us our eye is in pain.

Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 68 people in 16 states, including 5 cases of vision loss, as well as lung and urinary tract infections, and one death.

Researchers at the University of North Texas Health Science Center are the first to characterize extracellular vesicles in the tears of patients with keratoconus.

Studying mice, researchers at Washington University School of Medicine in St. Louis have found that proteins made by stem cells that regenerate the cornea may be new targets for treating and preventing corneal injuries in people with dry eye.

NEI grant will support examining impact of pain and inflammation on eye’s surface and possible link to diseases.

Scientists from Augusta University have fine-tuned a non-invasive and efficient way to evaluate the tear film for clues about wellness and disease.

Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid.